Navigation Links
Microneedles enhance drug administration through skin
Date:2/4/2008

LEXINGTON, Ky. (Feb. 4, 2008) − In what is believed to be the first peer-reviewed study of its kind involving human subjects, researchers at the University of Kentucky College of Pharmacy and the Georgia Institute of Technology have demonstrated that patches coated on one side with microscopic needles can facilitate transdermal delivery of clinically-relevant doses of a drug that normally cannot pass through the skin.

Reported in the journal Proceedings of the National Academy of Sciences, the study could help advance the use of microneedles as a painless method for delivering drugs, proteins, DNA and vaccines into the body. The research also found other advantages for the microneedles, including an ability to produce therapeutic drug levels with lower doses, and lowered production of metabolites that may cause side-effects.

This proof-of-concept study shows that microneedles work in humans for transdermal drug delivery, said Daniel Wermeling, associate professor in the Department of Pharmacy Practice and Science at UK's College of Pharmacy. Success with microneedles could cause us to rethink the convergence of the drug and delivery system and lead to a more integrated approach merging engineering with pharmaceutical technology.

The research was supported by the National Institutes of Health and the University of Kentucky Research Foundation.

This study represents an important landmark in the development of microneedles into drug delivery devices suitable for use in clinical medicine, said Mark Prausnitz, a professor in the School of Chemical and Biomolecular Engineering at the Georgia Institute of Technology. This method may be useful for a broad range of drugs that cannot normally be delivered without a hypodermic needle.

Transdermal drug delivery has proven successful in a number of applications, including pain management, congestive heart failure and hormone replacement. Transdermal administration offers advantages over o
'/>"/>

Contact: Ann Blackford
ann.blackford@uky.edu
859-323-6363
University of Kentucky
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. T cell immunity enhanced by timing of interleukin-7 therapy
2. Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI)
3. Align Technology Launches Aligntech Institute to Help Invisalign Providers Enhance Treatment Success and Practice Economics
4. Companys Award-Winning Sound Enhancement Technology Proven to Provide Superior Performance Over Other Technologies; Patent Will Enhance Able Planet, LINX AUDIO Brands
5. Technique enhances digital television viewing for visually-impaired
6. Fusion Energy Teams Up With BPs am/pm Stores to Enhance Supercross Sponsorship and Fusion Energy Products Distribution
7. AAPPO and HCAA Form Partnership to Enhance Services to Meet the Changing Business Needs of PPOs and TPAs
8. Z-shaped incision enhances minimally invasive surgery
9. Z-shaped incision enhances minimally-invasive surgery
10. QLT Appoints Goldman, Sachs & Co. as financial advisor in review of strategic options to enhance shareholder value
11. Advanced Clinical Research Services Enhances Biostatistics Offering
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Microneedles enhance drug administration through skin
(Date:7/1/2015)... ... July 01, 2015 , ... There is nothing ... have been arguing over laws governing sexuality since the first Pilgrims landed at ... historical comparative biography by Cindy Safronoff reveals. Crossing Swords: Mary Baker Eddy vs. ...
(Date:7/1/2015)... ... 2015 , ... DIC Corporation today announced the on-schedule completion ... food coloring. Construction of the plant, which is located on the site of ... May 2014. After commissioning, commercial production is expected to begin in September. A ...
(Date:7/1/2015)... ... July 01, 2015 , ... Summer recess has a whole new meaning. Thanks ... chins with plastic surgery when they’re looking for a boost in self-esteem. According to ... were performed on patients ages 19 and younger in 2012, an increase from previous ...
(Date:7/1/2015)... ... July 01, 2015 , ... As if mood swings, cramps and ... significant number of women: leg pain. Northeast Houston Vein Center is offering tips on ... of venous reflux disease, is underdiagnosed and often overlooked. Many women experience the tiredness, ...
(Date:7/1/2015)... ... 2015 , ... Scoliosis is a disorder in which the normally straight vertical line of the ... 3 percent of the population, or an estimated 6 to 9 million people. While it ... ages of 10 and 15. Most types of scoliosis are more common in girls than ...
Breaking Medicine News(10 mins):Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 2Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 3Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4
... in New Brunswick, New Jersey have reported that breast ... wetting //as children since they seem to have a ... inferring that breast-feeding protects against bed-wetting and our results ... added that there was sufficient evidence that bed-wetting can ...
... in China, doctors have successfully transplanted the heart of ... organs from people whom Chinese traditionally do not consider ... a heart extracted from a brain-dead patient, the surgery ... director of Institute of Organ Transplantation of Tongji Hospital ...
... Malaria has claimed 40 lives in Meghalaya so far this ... today//. ,Replying to a calling attention notice, ... seven from South Garo, six from East Garo Hills, nine ... district reported three deaths., ,This year, there has been ...
... Animal Husbandry Minister C. Divakaran Wednesday confirmed that pig fever ... pigs at a private farminwayanad//. ,This is believed to ... country. ,"Pig fever was ascribed to the death ... Pradesh after samples were send to them," said Divakaran. ...
... cannot coexist, because heat is capable of relieving pain, say ... DNA technology//, scientists were able to understand the behavior of ... on, it has a pain relieving effect. Scientists rated the ... pain killer, because pain receptors are turned off at the ...
... of Australia, Alexander Downer has sanctioned $17 million to ... of HIV-AIDS//, tuberculosis and malaria. ,To quote Mr. ... a million people to be treated with anti-retroviral drugs ... treated for tuberculosis. More than 11 million insecticide-treated bed ...
Cached Medicine News:
(Date:7/1/2015)... Ill. , July 1, 2015 ... nationwide group of state and regional professional rheumatology ... survey of rheumatologists that explored perceptions of biosimilars ... on patients. Biosimilars are medicines ... biologic medicines. They are notably different from generic ...
(Date:7/1/2015)... 1, 2015 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... corporate presentation at the Cantor Fitzgerald Healthcare Conference in ... Russell Cox , executive vice president and chief ... a business and financial update on Wednesday, July 8, 2015 ... A live audio webcast of the presentation may be ...
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... Fitzgerald Inaugural Healthcare Conference taking place in ... at Le Parker Meridien Hotel. ... overview of the Company,s business during his live presentation ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... 3 Glufosfamide and Phase 2 Glufosfamide Plus ... Gemcitabine Clinical Trials to be Presented, REDWOOD CITY, Calif., ... announced two presentations,regarding its oncology product candidate glufosfamide. The presentations,will ... held,September 23 to 27, 2007, at the International Conference Center ...
... First Hsp90 Inhibitor to Enter Registration Trials, HAYWARD, ... ) today announced that it has successfully,reached a binding ... the design of its TIME-1 clinical trial, a pivotal ... treatment for patients with,multiple myeloma. Through the FDA,s Special ...
Cached Medicine Technology:Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 2Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: